BiOptix Diagnostics Secures $6,228,202 New Funding Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=783f887e-8007-48de-9ad9-6f97017a59d7&Preview=1 - Date
3/14/2013 - Company Name
BiOptix Diagnostics - Mailing Address
1775 38th St. Boulder, CO 80301 - Company Description
The company’s mission is to develop its proprietary E-SPR (Enhanced Surface Plasmon Resonance) technology platform for the detection of molecular interactions. - Website
http://www.bioptix.com - Transaction Type
Venture Equity - Transaction Amount
$6,228,202 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. - M&A Terms
- Venture Investor
Undisclosed
